Novasol Chemicals has joined forces with Hivest Capital Partners
December 2025 — Novasol Chemicals, a dynamic and rapidly expanding global distributor of specialty chemicals, has entered into a financial partnership with Hivest Capital Partners to support its next phase of growth. The partnership is intended to accelerate Novasol’s international expansion, with a focus on both organic growth and selective acquisitions, further strengthening the company’s position in a highly fragmented market.
Novasol Chemicals is a global specialty chemical distributor with a diversified product portfolio across high-value end markets such as pharmaceuticals; agrochemicals; personal care; coatings, adhesives, sealants and elastomers (CASE); polymers; and energy and environment. Founded in 1997, Novasol has grown into an international chemical distribution platform with operations across Europe, North America and Asia. The company distributes specialty chemicals and ingredients to more than 500 clients in over 50 countries, leveraging a broad product portfolio and strong technical expertise across two main verticals, life sciences and material sciences. In recent years, Novasol has reinforced its organization through the establishment of a seasoned management team and the professionalization of its governance structure. The company has expanded into new geographies, including Turkey and Poland, while strengthening its presence in North America. In parallel, Novasol has launched environmental, social and governance (ESG) initiatives, including more sustainable packaging and logistics practices, as well as enhanced transparency and responsible practices across its supply chain.
Hivest Capital Partners is an independent European private equity firm authorized by the Financial Markets Authority, managing close to US$1.2 billion in assets. The firm invests in mid-sized businesses with revenues generally ranging from US$58 million to US$580 million, supporting management teams through innovative growth strategies and operational performance improvements.
Our role in the transaction
Oaklins’ team in Belgium acted as the exclusive sell-side M&A advisor to the shareholders of Novasol Chemicals in connection with the financial partnership involving Hivest Capital Partners.
François-Xavier Coiffard and Annie Okmez
Shareholders, Novasol Chemicals
Talk to the deal team
Pieter Vanhoudt
Oaklins KBC Securities
Emily Vandewoude
Oaklins KBC Securities
Related deals
Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreGP-Connect has joined forces with Transformation Capital to accelerate growth
Transformation Capital, a Netherlands-based investment firm, has joined forces with GP-Connect, a leading international secondment platform with specialized brands serving the hospitality, IT, skilled labor, technical services and dental sectors. As part of the transaction, GP-Connect welcomes Transformation Capital as its new shareholder to support the company’s next phase of growth, while the founders and existing shareholders will remain actively involved. The partnership will focus on executing a targeted buy-and-build strategy, expanding the business internationally and further strengthening GP-Connect’s portfolio.
Learn moreLemvig Biogasanlæg has been acquired by BioticNRG
BioticNRG has acquired Lemvig Biogasanlæg A.M.B.A. in a transaction that expands its presence in the biogas sector and establishes a strategic platform for further growth in the Danish renewable energy market. The acquisition supports the continued development of Lemvig Biogasanlæg while strengthening the production of green gas in Denmark.
Learn more